You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelin receptor antagonist

Showing 1 - 25 of 9,990
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin

Active, not recruiting
  • Pulmonary Arterial Hypertension
  • PDE5 inhibitor
  • Endothelin Receptor Antagonists
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 15, 2021

Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

Enrolling by invitation
  • Chronic Kidney Diseases
  • Aurora, Colorado
  • +5 more
Oct 18, 2022

After Changing Medication From Nonselective to Selective

Not yet recruiting
  • Eisenmenger Complex
    • (no location specified)
    Jan 26, 2021

    Kidney Failure, Acute Trial in Haifa (Ambrisentan 10 MG)

    Unknown status
    • Kidney Failure, Acute
    • Ambrisentan 10 MG
    • Haifa, Israel
    • +1 more
    Jun 24, 2020

    Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)

    Recruiting
    • Cardiac Allograft Vasculopathy
    • Los Angeles, California
      Ronald Regan UCLA Medical Center
    May 9, 2022

    Hypertension Trial in Augusta (Bosentan, Placebo)

    Active, not recruiting
    • Hypertension
    • Augusta, Georgia
      Georgia Regents University
    Jul 18, 2022

    Hypertension Trial in Augusta (Candesartan, Placebo)

    Active, not recruiting
    • Hypertension
    • Augusta, Georgia
      Georgia Prevention Institute/ Laboratory of Integrative and Exer
    Jul 18, 2022

    LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

    Not yet recruiting
    • LARS - Low Anterior Resection Syndrome
    • Seoul, Jongro-gu, Korea, Republic of
      Seoul National University Hospital
    Dec 13, 2022

    Bosentan in Myocardium Metabolism and Perfusion Measured by

    Terminated
    • Myocardial Dysfunction
    • Endothelial Dysfunction
      • Lausanne, Vaud, Switzerland
        Centre Hospitalier Universitaire Vaudois
      Mar 18, 2020

      Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

      Recruiting
      • Safety Issues
      • +2 more
      • Washington, District of Columbia
        Georgetown University
      Dec 1, 2022

      Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

      Not yet recruiting
      • Prostate Cancer
      • Prostate Adenocarcinoma
      • (no location specified)
      Feb 2, 2023

      Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

      Completed
      Has Results
      • Epidermolysis Bullosa
      • Serlopitant Tablet
      • Placebo Oral Tablet
      • Redwood City, California
        Stanford University
      Nov 30, 2022

      Monitoring Drug Efficacy in Patients With Alzheimer's Disease

      Recruiting
      • Alzheimer Disease
      • AChE inhibitor monotherapy
      • AChE inhibitor and NMDA receptor antagonist combination therapy
      • Manila, Metro Manila, Philippines
        Philippine General Hospital
      Mar 24, 2023

      Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

      Active, not recruiting
      • Prostatic Neoplasms
      • Beijing, China
      • +3 more
      Jan 17, 2023

      Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

      Recruiting
      • Rectal Cancer
      • Kineret 100 MG in 0.67 ML Prefilled Syringe
      • +3 more
      • Frankfurt, Germany
        University Hospital Goethe University Frankfurt
      Aug 23, 2022

      Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

      Recruiting
      • Sleep Initiation and Maintenance Disorders
      • Stress Disorders, Posttraumatic
      • San Francisco, California
      • +1 more
      Nov 10, 2022

      Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

      Not yet recruiting
      • Acute Respiratory Distress Syndrome
      • Placebo
      • Ondansetron Injection
      • Montréal, Quebec, Canada
        Hôpital Sacré-Coeur de Montréal
      Aug 22, 2022

      PTSD Trial in San Francisco (CORT108297, Placebo)

      Not yet recruiting
      • PTSD
      • San Francisco, California
        San Francisco VA Medical Center, San Francisco, CA
      Jul 26, 2022

      Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

      Recruiting
      • Rotator Cuff Tendinitis
      • Chronic Pain
      • Kristiansund, Norway
        Department of Orthopedic Surgery, Kristiansund Hospital
      Mar 15, 2022

      Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

      Not yet recruiting
      • Primary Aldosteronism
      • Hypertension
      • (no location specified)
      Apr 3, 2023

      COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

      Recruiting
      • COVID-19
      • SARS-CoV2 Infection
      • Candesartan Cilexetil
      • +3 more
      • Guntur, India
      • +4 more
      Mar 13, 2022

      Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)

      Recruiting
      • Cardiovascular Diseases
      • Vascular Dilation
      • Ifetroban Sodium
      • Placebo
      • Worcester, Massachusetts
        University of Massachusetts Medical School
      Feb 16, 2022

      Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 11, 2022

      Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

      Completed
      • Cardiac Failure
        • Wetzikon, Switzerland
          GZO Regional Health Center
        Jul 13, 2021

        Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

        Not yet recruiting
        • Depressive Disorder, Major
        • Anxiety Disorder
        • Nociceptin Receptor Antagonist
        • Aversive stimuli
        • (no location specified)
        Nov 3, 2022